Nice to see the green! The FINS were obviously not tempting

New Post Public Reply Private Reply Replies (1) Message Board
kilo Supernova #2218

Nice to see the green! The FINS were obviously not tempting to a lot of folks out there. It should have sparked a little confidence, but I believe many were hung up on Matt's salary. We need to look at the positive for once. It seems like every time something new comes out the bashers on "the place that shall remain nameless" grab one negative thing and people run with it! How many times is this going to happen? Folks, there will always be something about the company or Matt's decisions that we don't like. What needs to happen is we need to jump on the things we like. There sure are a lot of glass half empty types around here. Matt has consistantly proven that he is dedicated to the success here, he is putting stuff on the bottom line, and he is honest about it! Not a lot more I could ask for out of a OTC company CEO. Sure, I wish he would hurry some things along, we all do! But when you hurry you make mistakes like saying stuff that can't be like never and this will happen by this date. I hope my time in Florida will give me some positives to bring back here. Lord knows there is enough negative crap going on.

KILO

Baron Capital Enterprise, INC. (BCAP) Stock Research Links

BCAP Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

OnTime's Bold Vision: Transforming Home Healthcare Admin

Updated Category News Views 7

Changing the Game for Home Healthcare Every now and then, an idea rolls in that speaks to a real need, and OnTime's push to soften the burdens of the home healthcare industry might just be one of those. Built from grassroots experience, they're dropping efforts to modernize the back-end monotony so healthcare workers can zero in on, well, healthcare. A Nose-Dive into...

Continue Reading
Image Analysis Group Unveils DYNAMIKA V.7 for Clinical Trials

Updated Category News Views 185

Introduction to DYNAMIKA V.7 by Image Analysis Group Image Analysis Group (IAG) has recently launched DYNAMIKA V.7, an advanced cloud platform tailored for clinical trial imaging. Following stringent audits and certifications, including SOC II Type I compliance and British Standards Institute (BSI) surveillance audit certification, this platform stands out in its field....

Continue Reading
Sanofi's Strategic Move to Enhance Adult Vaccination Pipeline

Updated Category News Views 95

Sanofi Strengthens Its Vaccination Portfolio Sanofi SA (NASDAQ: SNY) has made a significant step in the healthcare sector by acquiring Dynavax Technologies Corporation (NASDAQ: DVAX) for approximately $2.2 billion. This acquisition, which involves a cash purchase price of $15.50 per share, signals Sanofi's commitment to enhancing its capabilities in the adult immunization...

Continue Reading
Miral Impact Fund: A New Era for Community and Environment

Updated Category News Views 135

Introducing the Miral Impact Fund Miral has taken a significant step towards environmental stewardship and social responsibility by launching the Miral Impact Fund. This initiative, launched in partnership with the Authority of Social Contribution – Ma'an, aims to create a positive impact within communities by addressing pressing social issues while promoting...

Continue Reading
Class Action Update for Regeneron Pharmaceuticals Investors

Updated Category News Views 125

Class Action Lawsuit Overview for Regeneron Pharmaceuticals Levi & Korsinsky, LLP has announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) investors should take note of a pending class action lawsuit concerning alleged securities fraud. Understanding the Class Action The lawsuit aims to recover losses for investors adversely affected by claims of fraud that...

Continue Reading